HeartBeam, Inc. (BEAT) vs Rockwell Medical, Inc. (RMTI)
A side-by-side comparison of HeartBeam, Inc. and Rockwell Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BEAT
HeartBeam, Inc.
$0.57HealthcareDelayed quote: Oct 6, 2026, 3:59 PM EDT
RMTI
Rockwell Medical, Inc.
$7.58HealthcareDelayed quote: Oct 6, 2026, 3:59 PM EDT
Total return — BEAT vs RMTI
growth of $100 · dividends reinvested · last 5yBEAT -86.1% (-32.6%/yr)RMTI -86.4% (-32.9%/yr)BEAT compounded faster over this window
BEAT RMTI
BEAT vs RMTI: by the numbers
- •BEAT is the larger company ($32M vs $30M market cap).
- •Both run net losses; BEAT's is the smaller (0.00% vs -7.33% net margin).
Metrics side by side
Valuation
| Metric | BEAT | RMTI |
|---|---|---|
| P/S ratio | N/A | 0.43 |
| P/B ratio | 3.89 | 0.85 |
| FCF yield | N/A | 5.15% |
Profitability
| Metric | BEAT | RMTI |
|---|---|---|
| Gross margin | 0.00% | 17.71% |
| Operating margin | 0.00% | -6.52% |
| Net margin | 0.00% | -7.33% |
| ROE | -248.21% | -14.49% |
| ROIC | -249.58% | -9.60% |
Growth (annualized)
| Metric | BEAT | RMTI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 2.59% |
| Total return CAGR (5Y) | N/A | -33.38% |
Go deeper
Dig into the metrics
HeartBeam ROERockwell Medical ROEHeartBeam operating marginRockwell Medical operating marginHeartBeam revenue growthRockwell Medical revenue growthHeartBeam free cash flowRockwell Medical free cash flow
HeartBeam & Rockwell Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.